Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 95

1.

Breast Ductal Carcinoma in Situ: Precursor to Invasive Breast Cancer.

Coleman WB.

Am J Pathol. 2019 May;189(5):942-945. doi: 10.1016/j.ajpath.2019.03.002.

PMID:
31029232
2.

Somatic Mutation Analysis of Human Cancers: Challenges in Clinical Practice.

Tsongalis GJ, Coleman WB.

J Clin Pharmacol. 2017 Oct;57 Suppl 10:S60-S66. doi: 10.1002/jcph.934.

PMID:
28921651
3.

Next-Generation Breast Cancer Omics.

Coleman WB.

Am J Pathol. 2017 Oct;187(10):2130-2132. doi: 10.1016/j.ajpath.2017.07.011. Epub 2017 Aug 16.

PMID:
28822804
4.

Discerning Clinical Responses in Breast Cancer Based On Molecular Signatures.

Coleman WB, Anders CK.

Am J Pathol. 2017 Oct;187(10):2199-2207. doi: 10.1016/j.ajpath.2017.08.002. Epub 2017 Aug 16. Review.

PMID:
28822803
5.

Obesity and the breast cancer methylome.

Coleman WB.

Curr Opin Pharmacol. 2016 Dec;31:104-113. doi: 10.1016/j.coph.2016.11.006. Epub 2016 Nov 23. Review.

PMID:
27886642
6.

Genomic Catastrophe and Neoplastic Transformation.

Coleman WB.

Am J Pathol. 2015 Jul;185(7):1846-9. doi: 10.1016/j.ajpath.2015.05.001. No abstract available.

PMID:
26093982
7.

Dysregulation of the epigenome in human breast cancer: contributions of gene-specific DNA hypermethylation to breast cancer pathobiology and targeting the breast cancer methylome for improved therapy.

Sandhu R, Roll JD, Rivenbark AG, Coleman WB.

Am J Pathol. 2015 Feb;185(2):282-92. doi: 10.1016/j.ajpath.2014.12.003. Epub 2014 Dec 23. Review.

PMID:
25541331
8.

Dysregulation of microRNA expression drives aberrant DNA hypermethylation in basal-like breast cancer.

Sandhu R, Rivenbark AG, Mackler RM, Livasy CA, Coleman WB.

Int J Oncol. 2014 Feb;44(2):563-72. doi: 10.3892/ijo.2013.2197. Epub 2013 Nov 29.

9.

Dysregulation of the epigenome in triple-negative breast cancers: basal-like and claudin-low breast cancers express aberrant DNA hypermethylation.

Roll JD, Rivenbark AG, Sandhu R, Parker JS, Jones WD, Carey LA, Livasy CA, Coleman WB.

Exp Mol Pathol. 2013 Dec;95(3):276-87. doi: 10.1016/j.yexmp.2013.09.001. Epub 2013 Sep 14.

PMID:
24045095
10.

Molecular and cellular heterogeneity in breast cancer: challenges for personalized medicine.

Rivenbark AG, O'Connor SM, Coleman WB.

Am J Pathol. 2013 Oct;183(4):1113-1124. doi: 10.1016/j.ajpath.2013.08.002. Epub 2013 Aug 27. Review.

11.

Breast cancer personalized medicine: challenges and opportunities.

Coleman WB.

Am J Pathol. 2013 Oct;183(4):1036-1037. doi: 10.1016/j.ajpath.2013.08.001. Epub 2013 Aug 23. No abstract available.

12.

Field cancerization in mammary carcinogenesis - Implications for prevention and treatment of breast cancer.

Rivenbark AG, Coleman WB.

Exp Mol Pathol. 2012 Dec;93(3):391-8. doi: 10.1016/j.yexmp.2012.10.018. Epub 2012 Nov 6. Review.

PMID:
23142414
13.
14.

Activation and regulation of reserve liver progenitor cells.

Best DH, Coleman WB.

Vitam Horm. 2011;87:93-109. doi: 10.1016/B978-0-12-386015-6.00026-3. Review.

PMID:
22127239
15.

Enhancement of chemotherapeutic efficacy in hypermethylator breast cancer cells through targeted and pharmacologic inhibition of DNMT3b.

Sandhu R, Rivenbark AG, Coleman WB.

Breast Cancer Res Treat. 2012 Jan;131(2):385-99. doi: 10.1007/s10549-011-1409-2. Epub 2011 Feb 27.

PMID:
21359954
16.

Lipoprotein lipase links dietary fat to solid tumor cell proliferation.

Kuemmerle NB, Rysman E, Lombardo PS, Flanagan AJ, Lipe BC, Wells WA, Pettus JR, Froehlich HM, Memoli VA, Morganelli PM, Swinnen JV, Timmerman LA, Chaychi L, Fricano CJ, Eisenberg BL, Coleman WB, Kinlaw WB.

Mol Cancer Ther. 2011 Mar;10(3):427-36. doi: 10.1158/1535-7163.MCT-10-0802. Epub 2011 Jan 31.

17.

Epstein-Barr virus-specific methylation of human genes in gastric cancer cells.

Ryan JL, Jones RJ, Kenney SC, Rivenbark AG, Tang W, Knight ER, Coleman WB, Gulley ML.

Infect Agent Cancer. 2010 Dec 31;5:27. doi: 10.1186/1750-9378-5-27.

18.

Exogenous expression of synaptotagmin XIII suppresses the neoplastic phenotype of a rat liver tumor cell line through molecular pathways related to mesenchymal to epithelial transition.

Jahn JE, Best DH, Coleman WB.

Exp Mol Pathol. 2010 Dec;89(3):209-16. doi: 10.1016/j.yexmp.2010.09.001. Epub 2010 Sep 16.

PMID:
20840848
19.

Liver regeneration by small hepatocyte-like progenitor cells after necrotic injury by carbon tetrachloride in retrorsine-exposed rats.

Best DH, Coleman WB.

Exp Mol Pathol. 2010 Oct;89(2):92-8. doi: 10.1016/j.yexmp.2010.06.007. Epub 2010 Jul 1.

PMID:
20599936
20.

Cytokine-dependent activation of small hepatocyte-like progenitor cells in retrorsine-induced rat liver injury.

Best DH, Butz GM, Coleman WB.

Exp Mol Pathol. 2010 Feb;88(1):7-14. doi: 10.1016/j.yexmp.2009.10.009. Epub 2009 Oct 27.

PMID:
19874816
21.

Epigenetic regulation of cystatins in cancer.

Rivenbark AG, Coleman WB.

Front Biosci (Landmark Ed). 2009 Jan 1;14:453-62. Review.

PMID:
19273077
22.

Molecular discrimination of multiple primary versus metastatic squamous cell cancers of the head/neck and lung.

Mercer RR, Lucas NC, Simmons AN, Zander DS, Tsongalis GJ, Funkhouser WK, Coleman WB.

Exp Mol Pathol. 2009 Feb;86(1):1-9. doi: 10.1016/j.yexmp.2008.11.003. Epub 2008 Nov 27.

PMID:
19094981
23.

pRb2/p130: a gene target for diagnosis and treatment of cancer.

Coleman WB, Rivenbark AG.

Expert Opin Med Diagn. 2008 Oct;2(10):1197-203. doi: 10.1517/17530059.2.10.1197.

PMID:
23496428
24.

DNMT3b overexpression contributes to a hypermethylator phenotype in human breast cancer cell lines.

Roll JD, Rivenbark AG, Jones WD, Coleman WB.

Mol Cancer. 2008 Jan 25;7:15. doi: 10.1186/1476-4598-7-15.

25.
26.

Cells of origin of small hepatocyte-like progenitor cells in the retrorsine model of rat liver injury and regeneration.

Hunter Best D, Coleman WB.

J Hepatol. 2008 Feb;48(2):369-71. Epub 2007 Nov 29. No abstract available.

PMID:
18086505
27.

DNA methylation-dependent epigenetic regulation of gene expression in MCF-7 breast cancer cells.

Rivenbark AG, Jones WD, Risher JD, Coleman WB.

Epigenetics. 2006 Jan-Mar;1(1):32-44. Epub 2005 Nov 18.

PMID:
17998816
28.

Practical applications for epigenetic biomarkers in cancer diagnostics.

Rivenbark AG, Coleman WB.

Expert Opin Med Diagn. 2007 Sep;1(1):17-30. doi: 10.1517/17530059.1.1.17.

PMID:
23489266
30.

Calcium signals induce liver stem cells to acquire a cardiac phenotype.

Anderson PA, Muller-Borer BJ, Esch GL, Coleman WB, Grisham JW, Malouf NN.

Cell Cycle. 2007 Jul 1;6(13):1565-9. Epub 2007 May 18. Review.

PMID:
17603299
31.

Methylation-dependent silencing of CST6 in primary human breast tumors and metastatic lesions.

Rivenbark AG, Livasy CA, Boyd CE, Keppler D, Coleman WB.

Exp Mol Pathol. 2007 Oct;83(2):188-97. Epub 2007 Apr 18.

32.
33.
34.

Dissecting the molecular mechanisms of cancer through bioinformatics-based experimental approaches.

Rivenbark AG, Coleman WB.

J Cell Biochem. 2007 Aug 1;101(5):1074-86. Review.

PMID:
17372928
35.

Mechanisms controlling the acquisition of a cardiac phenotype by liver stem cells.

Muller-Borer BJ, Cascio WE, Esch GL, Kim HS, Coleman WB, Grisham JW, Anderson PA, Malouf NN.

Proc Natl Acad Sci U S A. 2007 Mar 6;104(10):3877-82. Epub 2007 Feb 26.

36.

DNA methylation-dependent silencing of CST6 in human breast cancer cell lines.

Rivenbark AG, Jones WD, Coleman WB.

Lab Invest. 2006 Dec;86(12):1233-42. Epub 2006 Oct 16.

37.
38.

Molecular mechanisms of human carcinogenesis.

Coleman WB, Tsongalis GJ.

EXS. 2006;(96):321-49. Review.

PMID:
16383025
39.

Clinical genotyping: the need for interrogation of single nucleotide polymorphisms and mutations in the clinical laboratory.

Tsongalis GJ, Coleman WB.

Clin Chim Acta. 2006 Jan;363(1-2):127-37. Epub 2005 Aug 15. Review.

PMID:
16102741
40.

Adult-derived liver stem cells acquire a cardiomyocyte structural and functional phenotype ex vivo.

Muller-Borer BJ, Cascio WE, Anderson PA, Snowwaert JN, Frye JR, Desai N, Esch GL, Brackham JA, Bagnell CR, Coleman WB, Grisham JW, Malouf NN.

Am J Pathol. 2004 Jul;165(1):135-45.

41.
42.

Cancer bioinformatics: addressing the challenges of integrated postgenomic cancer research.

Coleman WB.

Cancer Invest. 2004;22(1):161-3. No abstract available.

PMID:
15069774
43.

Mechanisms of human hepatocarcinogenesis.

Coleman WB.

Curr Mol Med. 2003 Sep;3(6):573-88. Review.

PMID:
14527088
44.

Alu profiling of primary and metastatic nonsmall cell lung cancer.

Furmaga WB, Ryan JL, Coleman WB, Cole SR, Tsongalis GJ.

Exp Mol Pathol. 2003 Jun;74(3):224-9.

PMID:
12782008
45.
46.

Identification of three 11p11.2 candidate liver tumor suppressors through analysis of known human genes.

Ricketts SL, Carter JC, Coleman WB.

Mol Carcinog. 2003 Feb;36(2):90-9.

PMID:
12557265
47.

Molecular regulation of hepatocyte generation in adult animals.

Grisham JW, Coleman WB.

Am J Pathol. 2002 Oct;161(4):1107-10. Review. No abstract available.

48.

Isolation, short-term culture, and transplantation of small hepatocyte-like progenitor cells from retrorsine-exposed rats.

Gordon GJ, Butz GM, Grisham JW, Coleman WB.

Transplantation. 2002 Apr 27;73(8):1236-43.

PMID:
11981414
49.

Suppression of tumorigenicity of rat liver tumor cells by human chromosome 13: evidence against the involvement of pRb and BRCA2.

Rider MA, Butz GM, Ricketts SL, Newberry ST, Grisham JW, Coleman WB.

Int J Oncol. 2002 Feb;20(2):235-45.

PMID:
11788883
50.

Identification of candidate liver tumor suppressor genes from human 11p11.2-p12.

Ricketts SL, Garcia NF, Betz BL, Coleman WB.

Genes Chromosomes Cancer. 2002 Jan;33(1):47-59.

PMID:
11746987

Supplemental Content

Loading ...
Support Center